Previous studies have indicated that turkey erythrocyte and rat liver membranes contain endogenous a,c heterodimeric insulin receptors in addition to the disulphide-linked a2/32 heterotetrameric complexes characteristic of most cell types. We utilized '251-insulin affinity cross-linking to examine the structural properties of insulin receptors from rat liver and turkey erythrocyte membranes prepared in the absence and presence of sulphydryl alkylating agents. Rat liver membranes prepared in the absence of sulphydryl alkylating agents displayed specific labelling of Mr 400000 and 200000 bands, corresponding to the a2fl2 heterotetrameric and a, heterodimeric insulin receptor complexes respectively. In contrast, affinity cross-linking of membranes prepared with iodoacetamide (IAN) or N-ethylmaleimide identified predominantly the a2/J2 heterotetrameric insulin receptor complex. Similarly, affinity cross-linking and solubilization of intact turkey erythrocytes in the presence of IAN resulted in exclusive labelling of the a,2,2 heterotetrameric insulin receptor complex, whereas in the absence of IAN both a2/J2 and a,t species were observed. Turkey erythrocyte a2/12 heterotetrameric insulin receptors from IAN-protected membranes displayed a 3-4-fold stimulation of /8 subunit autophosphorylation and substrate phosphorylation by insulin, equivalent to that observed in intact human placenta insulin receptors. Turkey erythrocyte a,8 heterodimeric insulin receptors, prepared by defined pH/dithiothreitol treatment of IAN-protected membranes, were also fully competent in insulin-stimulated protein kinase activity compared with a,4 heterodimeric human placenta receptors. In contrast, endogenous turkey erythrocyte a,8i heterodimeric insulin receptors displayed basal protein kinase activity which was insulin-insensitive. These data indicate that native turkey erythrocyte and rat liver insulin receptors are structurally and functionally similar to alxJ2 heterotetrameric human placenta insulin receptors. The ac/ heterodimeric insulin receptors previously identified in these tissues most likely resulted from disulphide bond reduction and denaturation of the a2/12 holoreceptor complexes during membrane preparation.
INTRODUCTION
In most tissues and species examined, the mature insulin holoreceptor is minimally composed of two identical a subunits (Mr 135000) and two identical , subunits (Mr 95000) which are disulphide-linked into an a2/h heterotetrameric complex (for reviews, see Czech, 1985; Kahn, 1985; Pessin et al., 1985; Goldfine, 1987) . However, insulin receptors in membrane preparations from avian erythrocytes and from rat and shark liver have been observed to exist in an Mr-200000 a4l heterodimeric state (Aiyer, 1983a,b; Koch et al., 1986; Haynes et al., 1986; Stuart, 1988) . Structural heterogeneity of insulin receptors could have profound effects on transmembrane signalling, activation of the intrinsic protein tyrosine kinase activity and the elicitation of biological responsiveness. For example, ac/ heterodimeric insulin receptors have been reported to be a highly kinase-active species (Fujita-Yamaguchi & Kathuria, 1985) , and these smaller receptor subunit forms have been implicated in altered biological responsiveness (Crettaz et al., 1984) .
In order to examine the minimal structural requirements of insulin-dependent receptor signalling, we have developed methodology to isolate functional a,# heterodimeric insulin receptor complexes from native human placenta a2/12 holoreceptors (BoniSchnetzler et al., 1986; Sweet et al., 1987a) . Our results indicate that isolated ac/ heterodimeric insulin receptors display markedly decreased binding affinity for insulin (Boni-Schnetzler et al., 1986 , 1987 Sweet et al., 1987b; Swanson & Pessin, 1989) and lack insulin-stimulated kinase activity when prevented from reassociating to the a2/12 heterotetrameric state (Boni-Schnetzler et al., 1986; Wilden et al., 1989a) . Since the isolated human placenta a,l heterodimeric insulin receptor itself does not undergo insulinstimulated activation of the intrinsic protein tyrosine kinase activity, it would be expected that cells largely characterized by the acc/ heterodimeric insulin receptor subtype would be less responsive and/or less sensitive to insulin. Alternatively, it is possible that a/i heterodimeric insulin receptors from other species or tissues could function as an insulin-dependent protein kinase. In either case, it is not clear whether a, heterodimeric insulin receptor complexes are endogenous to specific tissues such as avian erythrocytes and rat liver in vivo or whether they result from a selective reduction of the inter-heterodimeric (Class I) disulphide bonds of the holoreceptor complex during tissue processing in vitro. Therefore we have examined the structural and functional properties of insulin receptors isolated from turkey erythrocyte and rat liver membranes and have compared them with those of the well-characterized insulin receptor from human placenta membranes.
MATERIALS AND METHODS

Materials
Bovine serum albumin, bacitracin, protease inhibitors, iodoacetamide (IAN), wheat-germ agglutinin (WGA)-agarose and dithiothreitol (DTT) Welinda et al. (1984) at the Diabetes and Endocrinology Research Center, The University of Iowa.
Membrane preparation Membranes were prepared from freshly obtained human placenta by the procedure of Harrison & Itin (1980) and stored (10 mg/ml) at -70°C in 250 mM-sucrose, 10 mM-Tris/HCI, pH 7.6, 2mM-EDTA, 1 mM-phenylmethanesulphonyl fluoride (PMSF), 25 mM-benzamidine hydrochloride, 10 /tM-leupeptin, 50 trypsin-inhibitory units of aprotinin/ml, 1 mM-1,10-phenanthroline and I,zM-pepstatin A. Protein concentration was determined by a modification (Wang & Smith, 1975) of the method described by Lowry et al. (1951) . Turkey erythrocyte membranes were obtained from whole blood (4 litres) mixed with 200000 units of heparin during collection and filtered through several layers of cheesecloth. Plasma and white cells were removed by centrifugation at 2000 g for 10 min at 4 'C. Erythrocytes were washed six times by resuspension in ice-cold 0.9 % NaCl and centrifugation at 2000 g for O min at 4 'C. The erythrocyte pellet was stored in 0.9 % NaCl at 4 'C for 16 h, then cells were lysed in hypo-osmotic lysis buffer consisting of 8.5 mM-Tris/HCI, pH 7.8, 3 mM-NaCl, 1 mM-dextrose, 2 mM-MgCl2, 70,sM-PMSF and 2,uM-leupeptin. The lysate was repeatedly centrifuged at 3000 g at 4 'C and resuspended in lysis buffer until a haemoglobin-free supernatant was obtained. The pellets were resuspended in lysis buffer and homogenized in a Dounce homogenizer (25 strokes) using a Wheaton pestle A. The dounced homogenate was centrifuged at 6000 g for10 min at 4 'C, and the top layer consisting of the erythrocyte membranes was pooled and recentrifuged at 17 500 g to remove remaining nuclear material. Membranes were suspended in lysis buffer containing 0.2 mM-MgCl2, pelleted at 17500g, resuspended to approx. 1O mg/ml and stored at -70 'C until use. Membranes from turkey erythrocytes were also prepared in the presence of I mM-IAN (IAN-protected) to prevent sulphydryl reduction and possible structural alteration of the insulin receptor during the isolation procedure. In these experiments,I mM-IAN was included in the buffers used to wash and lyse the cells and during isolation of the plasma membrane fraction. The final membrane pellet was resuspended as described above in the absence of IAN. Membranes were prepared from freshly obtained livers from male Sprague-Dawley rats in the absence and presence of 20 mM-N-ethylmaleimide (NEM) as described (O'Hare & Pilch, 1989) .
Preparation of a4 heterodimeric insulin receptors
Human placenta and IAN-protected turkey erythrocyte membranes were incubated at 23 'C for 25 min at pH 8.5 by the addition of 1.0 M-Tris, pH 10, followed by incubation with 2.0mM-DTT for 5 min at 23 'C, as described by Swanson & Pessin (1989) . Membrane samples were then diluted with a 10-fold excess of 50mM-Tris, pH 8.5, 150mM-NaCl, 2mM-EDTA and 0.020% NaN3 (TEN buffer) at 4 'C and centrifuged for 20min at 48000g. The membrane pellets were washed and resuspended with TEN buffer, pH 8.5, and solubilized with 1 00/ Triton X-cif00 and 10 1m-leupeptin for 30min at 4°C, followed by microcentrifugation at 13000 g for 30 min at 4 0C.
WGA affinity chromatography
The solubilized membrane samples were applied to 0.5 ml of WGA-agarose and mixed at 4°C for 3-4 h. The resin was extensively washed with WGA equilibration buffer (50 mmHepes, pH 7.4,0.02% NaN3, 10 mM-MgCl2 and 0.1 0% Triton X-100), and receptors were eluted with 0.3 M-N-acetylglucosamine in 50 mM-Tris, pH 8.0, 0.02 % NaN3 and 0.05% Triton X-100.
Sucrose gradient velocity sedimentation
Insulin receptors were resolved by sucrose gradient velocity sedimentation (Boni-Schnetzler et al., 1986 ) using linear gradients of 5-20% (w/v) sucrose in 50 mM-Tris/HCI, pH 7.6, 0.1 % Triton X-100 and 0.02% NaN3 (11.5 ml) layered on a 0.5 ml 20 % sucrose cushion. WGA-agarose eluates (200,u1) were loaded on to the gradient and insulin receptor complexes were resolved by centrifugation at 100000 g for 19 h at 4 'C. Fractions (250, ul) were collected at a rate of 0. the bound hormone by the addition of 0.5 ml of 0.1 0% bovine yglobulin and 0.5 ml of 25 % poly(ethylene glycol) at 4°C, followed by microcentrifugation at 13000 g for 0 min. The pellets were washed with 1.0 ml of100% poly(ethylene glycol). Non-specific binding was determined in the presence of1 /tM unlabelled insulin.
1251-Insulin affinity cross-linking
251I-Insulin affinity cross-linking was performed using freshly obtained intact turkey erythrocytes following extensive washing with phosphate-buffered saline (PBS; 5 mM-Na2HPO4, 150 mmNaCl, pH 7.4). Erythrocytes (12 ml) were incubated for 30 min at 23 'C in the absence or presence of 10 mM-IAN in KRH buffer plus 0.10% BSA and 0.01 0% bacitracin. The cells were then incubated for 16 h with '251-insulin (0.25 nM) at 4 'C before the addition of 0.1 mM-DSS for 5 min. The reaction was terminated by the addition of 2.0 ml of 1 M-Tris, pH 10, for 15 min at 23 'C. Non-specific125I-insulin affinity cross-linking was determined by inclusion of 1 /tM unlabelled insulin in the initial preincubation.
The samples werecentrifuged at 3000 g and the cell pellet was washed three times in PBS in the presence or absence of 1 mm-IAN. The cell pellet was then solubilized for 30 min at 4 'C in 2 vol. of 50 mM-Tris/HCI pH 7.4, 150 mM-NaCl, I 00 Triton X-100, 1 % sodium deoxycholate and 0.10% SDS (RIPA buffer) containing I /IM-pepstatin A, 10 ,tM-leupeptin, and 1 mM-PMSF. Samples were centrifuged atO00000 g for 30 min at 4 'C and insulin receptors were partially purified by WGA-agarose affinity chromatography. The WGA-agarose eluates were mixed with Laemmli(1970) sample buffer (50 mm Tris/HCl, pH 6.9, 100 glycerol, 0.05 % Bromophenol Blue and I % SDS) and resolved by SDS/PAGE under non-reducing conditions. 1251-Insulin affinity cross-linking to membranes and solubilized receptors was performed as described above, except that reactions were terminated by the addition of Laemmli sample buffer.
Autophosphorylation and substrate phosphorylation of soluble insulin receptors WGA-agarose eluates (50,ul) were preincubated for 1 h at 23 'C in the absence or presence of 100nM-insulin and/or 10 mM-IAN, as indicated in the individual Figurelegends, plus 50mm -Hepes, pH 7.8,2mM-MnCl2and 10 mM-MgCl2. Autophosphorylation was initiated by the addition of [y_32P]ATP (1000 /m, 3 1Ci/nmol) and terminated after 5 min with Laemmli sample buffer. Exogenous substrate phosphorylation was determined by the addition of 2 mg of Glu: Tyr (4: 1) synthetic polymer/ml in the phosphorylation reaction and termination by trichloroacetic acid precipitation on to Whatman 3MM paper.
SDS/PAGE
Insulin affinity-cross-linked and [y-32P]ATP-autophosphorylated samples were run on non-reducing 3-10 % linear gradient polyacrylamide gels in the presence of SDS according to the procedure of Laemmli (1970) . Insulin receptor samples were mixed with Laemmli sample buffer and applied to the 3-10 % gels without heating. The gels were stained with Coomassie Brilliant Blue R, dried and autoradiographed with Kodak XAR-5 film using Cronex lightening-plus intensifying screens.
RESULTS
1251-Insuln affinity cross-linking to membranes
Insulin receptors from turkey erythrocyte and rat liver membranes were structurally analysed by 125I-insulin affinity cross-linking and compared with the well-characterized insulin receptors from human placenta membranes. Where indicated, the sulphydryl alkylating agent IAN was included in the crosslinking assay to prevent insulin-induced alterations in the association state of any endogenous a#l heterodimeric insulin receptors present (Wilden et al., 1989b) . 125I-Insulin affinity cross-linking of human placenta membranes resulted in the specific labelling of the Mr 40000 a2A2 heterotetrameric insulin receptor species (Fig. la, lanes 1 and 2) . 1251-Insulin affinity cross-linking to the afl heterodimeric human placenta insulin receptor, prepared by treatment of control placenta membranes under defined pH/DTT conditions, demonstrated the specific labelling of both the Mr400000 and 200000 insulin receptor bands (Fig. Ia, lanes 4 and 5) . However, incubation of the pH/DTT-treated placenta membranes with 1 mM-IAN resulted in the exclusive 1251-insulin affinity labelling of the M, 200000 a4 heterodimeric insulin receptor complex (Fig. la, lane 6) . These results are consistent with our previous observations that IAN specifically inhibits an insulin-induced covalent association of ax/ heterodimeric insulin receptors into a disulphide-linked a2J2 heterotetrameric state (Wilden et al., 1989b) . In contrast, pretreatment of the control human placenta membranes with IAN prior to 125I-insulin cross-linking had no effect on the existing native a2fl2 heterotetrameric complex (Fig. 1, lane 3) .
Turkey erythrocyte membranes were prepared from intact cells under control (absence of IAN) or IAN-protected conditions to determine the effect of sulphydryl alkylation during the membrane preparation procedure on insulin receptor structure. Membranes prepared in the presence of IAN were resuspended in IAN-free buffer prior to analyses. 125I-Insulin affinity crosslinking of the IAN-protected turkey erythrocyte membranes specifically identified the Mr 400000 a2/32 heterotetrameric insulin receptor complex (Fig. 1 b, lanes 1 and 2) . Furthermore, the addition of IAN during 1251-insulin affinity cross-linking of control turkey erythrocyte membranes did not significantly alter the relative proportions of labelled Mr-400000 and -200000 insulin receptor species (Fig. lb, lane 6 ). This is in direct contrast with human placenta at/ heterodimeric insulin receptors prepared by defined pH/DTT treatment (Fig. la, lanes 4 and 6). Taken together, these data suggest that the at8 heterodimeric insulin receptor complexes in control turkey erythrocyte membranes resulted from reduction of the a2/12 heterotetrameric complex during the membrane preparation procedure, (Fig. 3) . 1251-Insulin cross-linking of control turkey erythrocytes that were not treated with IAN resulted in the predominant labelling of the Mr-400000 ac2/2 heterotetrameric insulin receptor, and to a lesser degree of the Mr-200 000 a,cI heterodimeric complex (Fig. 3a, lanes 1 and 2) . In contrast, erythrocytes that were affinity cross-linked in the absence (Fig.  3b, lanes 1 and 2) or presence (Fig. 3b, lanes 3 and 4) Samples were then subjected to non-reducing SDS/PAGE (3-100 gels) and autoradiography.
a 7-fold insulin-stimulated increase in subunit labelling of the a2/12 heterotetrameric complex (Fig. 4a, lanes 1 and 2) Laemmli sample buffer. Samples were then subjected to non-reducing SDS/PAGE (3-10 % gels) and autoradiography. (Fig. 4b, lanes 3 and 4) . These data are consistent with our previous finding that non-covalent interactions between human placenta insulin receptor a4 heterodimers support insulinstimulated intrinsic protein tyrosine kinase activity when covalent association is specifically blocked by IAN (Wilden et al., 1989b) . As expected, insulin-stimulated autophosphorylation by the control a2,/2 heterotetrameric insulin receptors was unaffected by preincubation with 10 mM-IAN (Fig. 4a, lanes 3 and 4) .
WGA-agarose eluates were prepared from control turkey erythrocyte membranes (Fig. 5a ), IAN-protected turkey erythrocyte membranes (Fig. 5b ) and IAN-protected membranes which were alkaline-pH/DTT-treated to reduce the a2/32 heterotetrameric turkey erythrocyte insulin receptors to a, heterodimers under the same defined conditions used for human placenta membranes (Fig. Sc) . The WGA-agarose eluates were incubated with insulin in the absence (lane 2) or the presence (lane 4) of additional IAN prior to autophosphorylation. WGA-agarose eluates from the control turkey erythrocyte membrane preparations demonstrated a 6-fold insulin-stimulated autophosphorylation of the a2,f2 heterotetrameric insulin receptor complex (Fig. Sa, lanes 1 and 2> which was essentially unaltered by pretreatment with 10 mM-IAN in the autophosphorylation assay (Fig. 5a, lanes 3 and 4) . Although the control turkey erythrocyte preparations contain a substantial amount of az heterodimeric insulin receptor complexes (Fig. 1) , only a trace amount of insulin-stimulated autophosphorylation was detected in the Mr-200000 insulin receptor band (Fig. 5a , lane 2). The partially purified a2/32 heterotetrameric insulin receptors from IAN-protected turkey erythrocyte membranes displayed an approximate 7-fold insulin stimulation of a subunit autophosphorylation both in the absence (Fig. 5b, lanes 1 and 2) and in the presence (Fig. 5b, lanes 3 and 4) of 10 mM-IAN. Autophosphorylation of the WGA eluates from IAN-protected membranes which were alkaline-pH/DTT-treated to generate a4 heterodimeric insulin receptor complexes resulted in an insulininduced covalent association into a 32P-labelled a2cf2 heterotetrameric complex (Fig. 5c, lanes 1 and 2) . Incubation with 10 mM-IAN prior to the addition of insulin significantly inhibited the insulin-induced covalent association into the a2/?2 heterotetrameric state (Fig. 5c, lanes 3 and 4) .
Sucrose gradient velocity sedimentation
To further identify the kinase-active insulin receptor species in turkey erythrocyte membranes prepared in the absence of IAN, we isolated the individual a2/32 heterotetrameric and a4 heterodimeric insulin receptor complexes by sucrose gradient centrifugation and compared these with the insulin receptor complexes obtained from human placenta and turkey erythrocyte membranes treated under defined pH/DTT conditions (Fig. 6 ).
Sucrose gradient fractions from control human placenta insulin receptors displayed peak insulin binding at fraction 12 corresponding to the a2/h heterotetrameric complex (Fig. 6a) . Insulin receptors from alkaline-pH/DTT-treated placenta membranes migrated at fraction 22, corresponding to the azf heterodimeric species (Fig. 6a) . Solubilized control turkey erythrocyte membranes exhibited the presence of both the a2f32 heterotetrameric and a4 heterodimeric insulin receptor species (Fig. 6b) whereas the IAN-protected membranes displayed only the a2fJ2 heterotetrameric form of the insulin receptor (Fig. 6c) .
Alkaline-pH/DTT treatment of the IAN-protected turkey erythrocyte membranes resulted in the complete conversion of the a2fi2 heterotetrameric insulin receptors into the ax/ heterodimeric state (Fig. 6c) .
Insulin receptor substrate phosphorylation
The sucrose-gradient-isolated insulin receptor species were next examined for insulin-dependent tyrosine-specific exogenous protein kinase activity (Fig. 7) . The isolated insulin receptors were incubated with 1O mM-IAN either before (IAN+ Ins) or after (Ins + IAN) the addition of 100 nM-insulin to determine the effect of covalent association on substrate protein kinase activity.
Insulin stimulation resulted in an approx. 3-fold increase in exogenous substrate kinase activity in both the a2/32 heterotetrameric ([l) and ax/ heterodimeric (3) insulin receptors from human placenta membranes (Fig. 7a , Con versus Ins+ IAN). Pretreatment of either the a2/32 heterotetrameric or a4 heterodimeric human placenta insulin receptors with 10 mm-IAN did not alter the basal (IAN) or insulin-stimulated (IAN+ Ins) protein kinase activity.
In agreement with the results obtained for human placenta insulin receptors (Fig. 7a) (Fig. 7b, IAN versus  IAN + Ins) . In contrast, the a, heterodimeric insulin receptor Vol. 271 (b) (c) species isolated from control turkey erythrocyte membranes displayed basal protein kinase activity which was completely insulin-insensitive (-). Therefore, in control turkey erythrocyte membrane preparations which contain both a2,/2 and a, insulin receptor complexes (Fig. 6b) , only the a2,32 heterotetrameric holoreceptor appears to be an insulin-responsive kinase-active species (Fig. 7b) .
DISCUSSION
We have investigated the structure and function of insulin receptors in rat liver and turkey erythrocytes, based on previous observations that these tissues uniquely contain endogenous a, heterodimeric insulin receptor complexes (Aiyer, 1983a,b; Koch et al., 1986; Haynes et al., 1986 ). Our data demonstrate that both afl heterodimeric and a2/12 heterotetrameric insulin receptor species were present in turkey erythrocyte and rat liver membranes prepared in the absence of sulphydryl alkylating agents (Figs. I and 2) . However, membranes prepared in the (Fig. 3) . These data together indicate that a,/ heterodimeric insulin receptor complexes are not endogenous to rat liver or turkey erythrocytes, since the inclusion of IAN in the preparatory buffers completely blocked the appearance of the a4 heterodimeric species. We therefore conclude that the previous identification of a/8 heterodimeric insulin receptors in rat liver and turkey erythrocytes resulted from an artifactual reduction and dissociation of native a2/J2 insulin holoreceptors during the isolation process. Other experimental manipulations have been previously reported to alter the structure of insulin receptors prior to identification, including limited proteolysis during membrane isolation and SDS/heat-dependent intramolecular sulphydryl-disulphide exchange during electrophoresis (Boyle et al. 1985; Helmerhorst et al., 1986) . As (Aiyer, 1983a; Boyle et al., 1985; FujitaYamaguchi et al., 1983 ).
The endogenous a, heterodimeric insulin receptor from control turkey erythrocyte membranes is functionally different from a4 heterodimeric insulin receptors prepared by defined alkalinepH/DTT treatment of human placental membranes. Human placenta a,# heterodimeric insulin receptors displayed an insulindependent covalent association into an a2,82 heterotetrameric state, as detected both by '25I-insulin affinity cross-linking ( Fig.  I) and by , subunit autophosphorylation (Fig. 4) , in agreement with previous observations (Boni-Schnetzler et al., 1988; Morrison et al., 1988; Wilden et al., 1989b) . In contrast, the endogenously generated turkey erythrocyte membrane oz/ heterodimeric insulin receptors did not associate into covalent disulphide-linked a2,82 heterotetrameric complexes ( Figs. 1 and 5 ).
In addition, human placenta a, heterodimeric insulin receptor complexes prepared under defined alkaline-pH/DTT treatment displayed a 3-5-fold insulin stimulation of , subunit autophosphorylation (Fig. 4) and exogenous substrate phosphorylation ( Fig. 7) , whereas endogenous turkey erythrocyte a4 heterodimeric insulin receptors displayed basal protein kinase activity which was essentially insulin-insensitive. Thus the ax/ heterodimeric insulin receptors generated by the intrinsic reduction of turkey erythrocyte membranes are qualitatively different from the a4 heterodimers obtained by defined alkalinepH/DTT treatment of human placenta membranes. This cannot be accounted for by species/tissue differences alone, since turkey erythrocyte a,8 heterodimeric insulin receptors obtained by alkaline-pH/DTT treatment of IAN-protected a2/32 heterotetramers displayed insulin-stimulated autophosphorylation (Fig. 5 ) and substrate phosphorylation (Fig. 7) identical to the a, heterodimeric human placenta insulin receptor. We conclude that the kinase-inactive state of endogenous a4 heterodimeric turkey erythrocyte membrane insulin receptors results from reduction and denaturation during the receptor isolation procedure.
In summary, we have demonstrated that both native turkey erythrocyte and rat liver insulin receptors minimally exist in a disulphide-linked a2/32 heterotetrameric state. The presence of lower oligomeric states of the insulin receptors in isolated turkey erythrocyte and rat liver membranes results from an endogenous reduction/dissociation which occurs during the receptor isolation procedure. These endogenously generated a4 heterodimeric insulin receptor complexes are essentially kinase-inactive and insulin-insensitive. We conclude that native turkey erythrocyte and rat liver insulin receptors share the same a2x2 heterotetrameric structure and mechanism of protein kinase activation as observed for insulin receptors in human placental membranes, as well as other tissues.
